Free Trial
→ Your free book is about to disappear (From Profits Run) (Ad)tc pixel Free ONCSQ Stock Alerts

OncoSec Medical (ONCSQ) Competitors

Compare

ONCSQ vs. SXTPW, ADTX, BFRIW, CALA, and CINGW

Should you buy OncoSec Medical stock or one of its competitors? OncoSec Medical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Aditxt (ADTX), Biofrontera (BFRIW), Calithera Biosciences (CALA), and Cingulate (CINGW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does OncoSec Medical compare to 60 Degrees Pharmaceuticals?

OncoSec Medical (NASDAQ:ONCSQ) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for OncoSec Medical. 60 Degrees Pharmaceuticals' average media sentiment score of 1.82 beat OncoSec Medical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
60 Degrees Pharmaceuticals Very Positive

60 Degrees Pharmaceuticals has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Aditxt?

OncoSec Medical (NASDAQ:ONCSQ) and Aditxt (NASDAQ:ADTX) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

Given OncoSec Medical's higher possible upside, research analysts clearly believe OncoSec Medical is more favorable than Aditxt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OncoSec Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aditxt
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

OncoSec Medical has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. OncoSec Medical's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Aditxt -360,152.50%-374.60%-105.93%

15.5% of Aditxt shares are owned by institutional investors. 1.3% of OncoSec Medical shares are owned by company insiders. Comparatively, 0.0% of Aditxt shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

OncoSec Medical has higher earnings, but lower revenue than Aditxt. Aditxt is trading at a lower price-to-earnings ratio than OncoSec Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Aditxt$14.34K0.03-$41.71M-$100.79 thousandN/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Aditxt'saverage media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Aditxt Neutral

OncoSec Medical has a beta of -30.04, indicating that its share price is 3,104% less volatile than the broader market. Comparatively, Aditxt has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Summary

OncoSec Medical beats Aditxt on 7 of the 12 factors compared between the two stocks.

How does OncoSec Medical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

In the previous week, Biofrontera had 4 more articles in the media than OncoSec Medical. MarketBeat recorded 4 mentions for Biofrontera and 0 mentions for OncoSec Medical. Biofrontera's average media sentiment score of 0.93 beat OncoSec Medical's score of 0.00 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Positive
OncoSec Medical Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
OncoSec Medical N/A N/A N/A

Biofrontera has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Summary

Biofrontera beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Calithera Biosciences?

Calithera Biosciences (OTCMKTS:CALA) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Calithera Biosciences has a beta of -1.06, meaning that its stock price is 206% less volatile than the broader market. Comparatively, OncoSec Medical has a beta of -30.04, meaning that its stock price is 3,104% less volatile than the broader market.

In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Calithera Biosciences Neutral
OncoSec Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
OncoSec Medical N/A N/A N/A

Summary

Calithera Biosciences beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

How does OncoSec Medical compare to Cingulate?

OncoSec Medical (NASDAQ:ONCSQ) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for Cingulate and 0 mentions for OncoSec Medical. Cingulate's average media sentiment score of 1.82 beat OncoSec Medical's score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
Cingulate Very Positive

Summary

Cingulate beats OncoSec Medical on 2 of the 2 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

Export
MetricOncoSec MedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$13.78B$7.85B$12.00B
Dividend YieldN/A2.56%2.46%4.50%
P/E Ratio0.0029.5334.4330.31
Price / SalesN/A7.528.845.84
Price / CashN/A15.7922.2322.80
Price / BookN/A4.924.383.77
Net Income-$34.18M$2.87B$3.51B$390.69M

OncoSec Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/AN/A40
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-51.4%$0.00$1.11MN/A3
ADTX
Aditxt
0.0203 of 5 stars		$0.00
-20.0%		N/A-100.0%$0.00$14.34KN/A26
BFRIW
Biofrontera
N/A$0.00
flat		N/AN/A$0.00$46.18MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONCSQ) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Trump compared today's market to 1929
President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...
USA Capital Gold | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel